Sulfasalazine
13 NDCs across 4 manufacturers|13 Generic,0 Brand
Sulfasalazine is used to treat juvenile arthritis, rheumatoid arthritis and ulcerative colitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $19 million on Sulfasalazine across 583,000 claims for 149,000 beneficiaries.
Sulfasalazine is available as 13 NDCs from 4 manufacturers (13 generic, 0 brand), with NADAC prices from $0.20 to $0.29 per EA — a 44% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
13G / 0B
Manufacturers
4
competing in market
Price Spread
$0.20 – $0.29
per EA
7d Activity
avg -0.4% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Mylan Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Aminosalicylate class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing SULFASALAZINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SULFASALAZINE DR 500 MG TAB | $0.2859 per EA | +0.55% |
SULFASALAZINE DR 500 MG TAB | $0.2859 per EA | +0.55% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
SULFASALAZINE 500 MG TABLET | $0.1991 per EA | -0.62% |
Frequently Asked Questions
What is Sulfasalazine used to treat?
Sulfasalazine is used to treat juvenile arthritis, rheumatoid arthritis and ulcerative colitis, per the National Library of Medicine's MED-RT classification.
When did Sulfasalazine become available as a generic?
FDA approved the first generic Sulfasalazine (ANDA) on Jan 1, 1982. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Sulfasalazine?
In 2024, Medicare Part D spent $19 million on Sulfasalazine across 583,000 claims for 149,000 beneficiaries.
How many Sulfasalazine products are on the market?
The Sulfasalazine drug market contains 13 NDCs from 4 manufacturers — 13 generic and 0 brand products.
What is the price range for Sulfasalazine?
NADAC reference prices for Sulfasalazine range from $0.1991 to $0.2859 per EA — a 44% difference between cheapest and most expensive.
Which manufacturers make Sulfasalazine?
4 manufacturers list Sulfasalazine in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (4), Chartwell RX LLC (4), Teva Pharmaceuticals USA Inc. (3), Sunrise Pharmaceutical Inc. (2).
How has the price of Sulfasalazine changed recently?
Over the past 7 days, 2 Sulfasalazine NDCs rose and 11 fell, with a market-wide average change of -0.4%.